Publications

  1. Outcomes including liver histology after liver transplantation for chronic hepatitis B using oral antiviral therapy alone. Fung J, Lo R, Chan SC, Chok K, Wong T, Sharr W, Cheung TT, Chan AC, Dai WC, Sin SL, Ng I, Lai CL, Yuen MF, Lo CM.Liver Transpl. 2015 Jul 20.
  2. Comparison of Survival Outcomes between Right Posterior Sectionectomy And Right Hepatectomy For Hepatocellular Carcinoma In Cirrhotic Liver: A Single Centre Experience.Yip V, Lo CM, Cheung TT.
  3. New insights after the first 1000 liver transplantations at The University of Hong Kong. Chan SC, Cheung TT, Chan AC, Chok KS, Sharr WW, Fung JY, Liu CL, Fan ST, Lo CM.Asian J Surg. 2015 Jul 2. pii: S1015-9584(15)00065-2.
  4. Restoration of natural killer activity in hepatocellular carcinoma by treatment with antibody against granulin-epithelin precursor.Cheung PF, Yip CW, Ng LW, Wong CK, Cheung TT, Lo CM, Fan ST, Cheung ST. Oncoimmunology. 2015 Apr 1;4(7):e1016706.
  5. Outcomes of endo-radiological approach to management of bile leakage after right lobe living donor liver transplantation.Chok KS, Chan AC, Sharr WW, Cheung TT, Fung JY, Chan SC, Lo CM.J Gastroenterol Hepatol. 2015 Jun 23.
  6. Update in management of hepatocellular carcinoma in eastern population. Chu KW, Cheung TTWorld journal of hepatology 2015.
  7. Hong Kong consensus recommendations on the management of hepatocellular carcinoma. Poon RT, Cheung TT, Kwok PC, Lee AS, Li TW, Loke KL, Chan SL, Cheung MT, Lai TW, Cheung CC, Cheung FY, Loo CK, But YK, Hsu SJ, Yu SC, Yau T.Liver Cancer. 2015 Mar;4(1):51-69.
  8. Copy number gain of granulin-epithelin precursor (GEP) at chromosome 17q21 associates with overexpression in human liver cancer.Yung MK, Lo KW, Yip CW, Chung GT, Tong CY, Cheung PF, Cheung TT, Poon RT, So S, Fan ST, Cheung ST.BMC Cancer. 2015 Apr 11;15:264.
  9. Transplantation of a 2-year-old deceased-donor liver to a 61-year-old male recipient.Dai WC, Sharr WW, Chok KS, Cheung TT, Fung JY, Chan AC, Chan SC, Lo CM.Asian J Surg. 2015 Apr;38(2):113-116.
  10. Gastrointestinal bleeding of obscured origin due to cystic artery pseudoaneurysm.She WH, Tsang S, Poon R, Cheung TT.Asian J Surg. 2015 Mar 18. pii: S1015-9584(15)00003-2.
  11. Establishment and characterization of a novel primary hepatocellular carcinoma cell line with metastatic ability in vivo.Cheung PF, Yip CW, Ng LW, Lo KW, Wong N, Choy KW, Chow C, Chan KF, Cheung TT, Poon RT, Fan ST, Cheung ST.Cancer Cell Int. 2014 Oct 9;14(1):103.
  12. Granulin-epithelin precursor renders hepatocellular carcinoma cells resistant to natural killer cytotoxicity.Cheung PF, Yip CW, Wong NC, Fong DY, Ng LW, Wan AM, Wong CK, Cheung TT, Ng IO, Poon RT, Fan ST, Cheung ST.Cancer Immunol Res.
  13. Pancreaticoduodenectomy with vascular reconstruction for adenocarcinoma of the pancreas with borderline respectability.Cheung TT, Poon RT, Chok KSH, Chan AC, Tsang SH, Dai WC, Chan SC, Fan ST, Lo CM.World Journal of Gastroenterology 2014 Dec 14;20(46):17448-55.
  14. Cholangiography in ketamine user- An emerging new conditionCheung TT, Poon RT, Chan AC, Lo CM. J Gastroenterol Hepatol. 2014 Sep;29(9):1663.
  15. Management of spontaneously ruptured hepatocellular carcinomas in the radiofrequency ablation era. Cheung TT, Poon RT, Chok KS, Chan AC, Tsang SH, Dai WC, Yau TC, Chan SC, Fan ST, Lo CM. PLoS One. 2014 Apr 9;9(4):e94453.
  16. Improved anterior hepatic transection for isolated hepatocellular carcinoma in the caudate.Cheung TT, Yuen WK, Poon RT, Chan SC, Fan ST, Lo CM.Hepatobiliary Pancreat Dis Int. 2014 Apr;13(2):219-22. Retransplantation using living-donor right-liver grafts.Dai WC, Chan SC, Chok KS, Cheung TT, Sharr WW, Chan AC, Fung JY, Wong TC, Lo CM.J Hepatobiliary Pancreat Sci. 2014 Aug;21(8):579-84.
  17. Advanced Pancreatic Cancer: Flourishing Novel Approaches in the Era of Biological Therapy.Chiu JW, Wong H, Leung R, Pang R, Cheung TT, Fan ST, Poon R, Yau T.Oncologist. 2014 Aug 12. pii: theoncologist.2012-0131.
  18. Defining an optimal surgical strategy for synchronous colorectal liver metastases: staged versus simultaneous resection?She WH, Chan AC, Poon RT, Cheung TT, Chok KS, Chan SC, Lo CM.ANZ J Surg. 2014 Jul 1.
  19. Treatment Strategy to Improve Long-Term Survival for Hepatocellular Carcinoma Smaller than 5 cm: Major Hepatectomy vs Minor Hepatectomy.Wong TC, Cheung TT, Chok KS, Chan AC, Dai WC, Chan SC, Poon RT, Lo CM.World J Surg. 2014 Sep;38(9):2386-94.
  20. Pilot study of high-intensity focused ultrasound ablation as a bridging therapy for hepatocellular carcinoma patients wait-listed for liver transplantation.Chok KS, Cheung TT, Lo RC, Chu FS, Tsang SH, Chan AC, Sharr WW, Fung JY, Dai WC, Chan SC, Fan ST, Lo CM.Liver Transpl. 2014 Aug;20(8):912-21.
  21. Long term survival analysis of hepatectomy for neuroendocrine tumour liver metastases.Cheung TT, Chok KS, Chan AC, Tsang S, Dai JW, Lang BH, Yau T, Chan SC, Poon RT, Fan ST, Lo CM.ScientificWorldJournal. 2014 Jan 12;2014:524045.
  22. Laparoscopic versus open liver resection for elderly patients with malignant liver tumors: a single center experience.Chan AC, Poon RT, Cheung TT, Chok KS, Chiu DW, Chan SC, Lo CM.J Gastroenterol Hepatol. 2014 Feb 12.
  23. Good longterm survival after primary living donor liver transplantation for solitary hepatocellular carcinomas up to 8 cm in diameter.Dai WC, Chan SC, Chok KS, Cheung TT, Sharr WW, Chan AC, Tsang SH, Fung JY, Poon RT, Fan ST, Lo CM.HPB (Oxford). 2014 Jan 28.
  24. Survival analysis of high-intensity focused ultrasound therapy vs. transarterial chemoembolization for unresectable hepatocellular carcinomas.Cheung TT, Poon RT, Jenkins CR, Chu FS, Chok KS, Chan AC, Tsang SH, Dai WC, Yau TC, Chan SC, Fan ST, Lo CM.Liver Int. 2014 Jan 22.
  25. Long-term Survival Analysis of Pure Laparoscopic Versus Open Hepatectomy for Hepatocellular Carcinoma in Patients With Cirrhosis: A Single-Center Experience".Cheung TT, Poon RT, Lo CM.Ann Surg. 2013 Dec 26.
  26. Feasibility of Laparoscopic Re-resection for Patients with Recurrent Hepatocellular Carcinoma.Chan AC, Poon RT, Chok KS, Cheung TT, Chan SC, Lo CM.World J Surg. 2013 Dec 5.
  27. Perpetuating proficiency in donor right hepatectomy for living donor liver transplantation.Chan SC, Chan AC, Sharr WW, Chok KS, Cheung TT, Fan ST, Lo CM.Asian J Surg. 2013 Nov 5.
  28. Surgical Outcomes in Hepatocellular Carcinoma Patients with Portal Vein Tumor Thrombosis. Chok KS, Cheung TT, Chan SC, Poon RT, Fan ST, Lo CM.World J Surg. 2013 Oct 17.
  29. Retrohepatic vena cava deroofing in living donor liver transplantation for caudate hepatocellular carcinoma.Chan SC, Sharr WW, Cheung TT, Chan AC, Tsang SH, Chok KSh, Leung KC, Lo CM.Hepatobiliary Pancreat Dis Int. 2013 Oct;12(5):552-5.
  30. Use of liver stiffness measurement for liver resection surgery: correlation with indocyanine green clearance testing and post-operative outcome.Fung J, Poon RT, Yu WC, Chan SC, Chan AC, Chok KS, Cheung TT, Seto WK, Lo CM, Lai CL, Yuen MF. PLoS One. 2013 Aug 28;8(8):e72306.
  31. An unusual cause of acute abdomen-Gas-forming liver abscess due to Salmonella enteritidis.Yu HH, Tsang S, Cheung TT.Asian J Surg. 2013 Aug 23.
  32. Primary perivascular epithelioid cell tumour (PEComa) of the liver.Cheung TT, Trendell-Smith N, Poon RT.BMJ Case Rep. 2013 Jul 10;2013.
  33. Reply: Underestimated role of 18F-FDG PET for HCC evaluation and promise of 18F-FDG PET/MR imaging in this setting.Cheung TT, Ho CL, Chen S, Chan SC, Poon RT, Fan ST, Lo CM.J Nucl Med. 2013 Aug;54(8):1511-2.
  34. Survival outcome of re-resection for recurrent liver metastases of colorectal cancer: a retrospective study.Chok KS, Cheung TT, Chan AC, Dai WC, Chan SC, Fan ST, Poon RT, Lo CM.ANZ J Surg. 2013 Jun 30.
  35. Synchronous resections of primary colorectal tumor and liver metastasis by laparoscopic approach.Cheung TT, Poon RT.World J Hepatol. 2013 Jun 27;5(6):298-301.
  36. Survival outcomes of right-lobe living donor liver transplantation for patients with high Model for End-stage Liver Disease scores.Chok KSh, Chan SC, Fung JY, Cheung TT, Chan AC, Fan ST, Lo CM.Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):256-62.
  37. An Unusual Cause of Epigastric Pain.Cheung TT, Lo R, Poon RT.Gastroenterology. 2013 Mar 21.
  38. Long term survival analysis of hepatic resection for breast cancer metastases.Cheung TT, Chok KSH, Chan SC, Poon RPT, Fan ST, Lo CM Hepatogastroenterology 2013
  39. Analysis of long-term survival after hepatectomy for isolated liver metastasis of gastrointestinal stromal tumour. Cheung TT, Chok KSH, Chan SC, Poon RPT, Fan ST, Lo CM ANZ J Surg 2013
  40. Surviving emphysematous gastritis after hepatectomy.Yu HH, Tsang SH, Cheung TT, Lo CM.Case Reports in Hepatology, vol. 2013, Article ID 106383, 4 pages, 2013.
  41. Remnant left liver size and recovery of living right liver donors. YK Fong, SC Chan, TT Cheung, WC Dai, KSH Chok, ACY Chan, WW Sharr, CM Lo.Hepatology international 2012.
  42. Clinical staging and selection of patients with Hepatocellular carcinoma for liver transplant based on Milan Criteria by 11C-Acetate and 18F-FDG PET/CT - A Surgeon’s Perspective. Cheung TT, Chok KSH, Chan SC, Poon RPT, Fan ST, Lo CM.Journal of Nuclear Medicine 2013 Feb;54(2):192-200.
  43. Long term survival analysis of pure laparoscopic versus open hepatectomy for Hepatocellular carcinoma in patients with cirrhosis: A single center experience.Cheung TT, Chok KSH, Chan SC, Poon RPT, Fan ST, Lo CM Annals of Surgery 2013 Mar;257(3):506-11.
  44. Survival analysis of high intensity focused ultrasound ablation in patients with small HCC. Cheung TT, Chok KSH, Chan SC, Poon RPT, Fan ST, Lo CM. HPB Oxford 2012 Dec 4.
  45. High Intensity Focused Ultrasound as an Effective Bridging Therapy for Patient with HCC.Cheung TT, Chok KSH, Chan SC, Poon RPT, Fan ST, Lo CM.World Journal of Gastroenterology (In press) 2012
  46. Brunner’s gland adenoma: an unusual cause of duodenum haemorrhage and obstruction. Cheung TT, Trendel Smith, WK Ip, Poon RT.Hong Kong Medical Journal 2012.
  47. Technical note on complete excision of Choledochol cyst.Cheung TT, Fan ST.Hepatobiliary Pancreat Dis Int. 2013 Apr;12(2):218-21.
  48. Outcomes of Central Bisectionectomy for Hepatocellular Carcinoma.Chan AC, Poon RT, Cheung TT, Chok KS, Chan SC, Fan ST, Lo CM.HPB oxford 2012.
  49. Evaluation of the 7th AJCC TNM staging system for patients with curative resection for hepatocellular carcinoma: Implication for development of a refined staging system.Chan AC, Poon RT, Cheung TT, Chok KS, Chan SC, Fan ST, Lo CM.HPB oxford 2012.
  50. Rapid measurement of indocyanine green retention by pulse spectrophotometry – a validation study in 70 patients with Child-Pugh class A cirrhosis before hepatectomy for hepatocellular carcinoma. Cheung TT, Chok KSH, Chan SC, Poon RPT, Fan ST, Lo CM.Hepatobiliary Pancreat Dis Int. 2012 Jun;11(3):267-71.
  51. High-intensity focused ultrasound ablation as a bridging therapy for HCC patient awaiting liver transplantation.Cheung TT, Chok KSH, Chan SC, Poon RPT, Fan ST, Lo CM. Hepatobiliary Pancreat Dis Int. 2012 Oct;11(5):542-4.
  52. An update on Yttrium90-based radio-embolisation for treatment of hepatocellular carcinoma Kan RWM, Tsang SHY, Poon RTP, Cheung TT [Corresponding Authour] ANZ J Surg. 2012 Jul-Aug;82(7-8):505-9.
  53. Radiological prognosticators of hepatocellular carcinoma treated by hepatectomy. Chu KK, Chan SC, Fan ST, Chok KSh, Cheung TT, Sharr WW, Chan AC, Lo CM. Hepatobiliary Pancreat Dis Int. 2012 Dec;11(6):612-7.
  54. Outcome of laparoscopic versus open hepatectomy for colorectal liver metastases. Cheung TT, Poon RT, Yuen WK, Chok KS, Tsang SH, Yau T, Chan SC, Lo CM. ANZ J Surg. 2012 Oct 4.
  55. Tolerance of high-intensity focused ultrasound ablation in patients with hepatocellular carcinoma. Cheung TT, Chu FS, Jenkins CR, Tsang DS, Chok KS, Chan AC, Yau TC, Chan SC, Poon RT, Lo CM, Fan ST.World J Surg. 2012 Oct;36(10):2420-7.
  56. [18F]fluoroacetate positron emission tomography for hepatocellular carcinoma and metastases: an alternative tracer for [11C]acetate? Ho CL, Cheung MK, Chen S, Cheung TT, Leung YL, Cheng KC, Yeung WD. Mol Imaging. 2012 Jun;11(3):229-39.
  57. The use of single-agent sorafenib in the treatment of advanced hepatocellular carcinoma patients with underlying Child-Pugh B liver cirrhosis: a retrospective analysis of efficacy, safety, and survival benefits. Chiu J, Tang YF, Yao TJ, Wong A, Wong H, Leung R, Chan P, Cheung TT, Chan AC, Pang R, Fan ST, Poon R, Yau T.Cancer. 2012 Nov 1;118(21):5293-301.
  58. The impact of family history of hepatocellular carcinoma on its patients' survival. Dai WC, Fan ST, Cheung TT, Chok KS, Chan AC, Tsang SH, Poon RT, Lo CM. Hepatobiliary Pancreat Dis Int. 2012 Apr; 11(2):160-4.
  59. Phase II study of bevacizumab and erlotinib in the treatment of advanced hepatocellular carcinoma patients with sorafenib-refractory disease. Yau T, Wong H, Chan P, Yao TJ, Pang R, Cheung TT, Fan ST, Poon RT. Invest New Drugs. 2012 Dec;30(6):2384-90.
  60. Single-centre experience of liver transplantation for familial amyloidotic polyneuropathy of non-Val30Met variants in Chinese patients. Dai WC, Chan SC, Chok KS, Cheung TT, Sharr WW, Chan AC, Fung JY, Tsang SH, Fan ST, Lo CM. Amyloid. 2012 Mar;19(1):33-6. doi: 10.3109/13506129.2012.655867.
  61. Outcomes of living-donor liver transplantation in patients with preoperative type-1 hepatorenal syndrome and acute hepatic decompenation. Chok KS, Fung JY, Chan SC, Cheung TT, Sharr WW, Chan AC, Fan ST, Lo CM. Liver Transpl. 2012 Jan 30.
  62. Modulation of graft vascular inflow guided by flowmetry and manometry in liver transplantation. Chan SC, Lo CM, Chok KS, Sharr WW, Cheung TT, Tsang SH, Chan AC, Fan ST. Hepatobiliary Pancreat Dis Int. 2011 Dec;10(6):649-56.
  63. The Outcomes and Safety of Single-Agent Sorafenib in the Treatment of Elderly Patients with Advanced Hepatocellular Carcinoma (HCC). Wong H, Tang YF, Yao TJ, Chiu J, Leung R, Chan P, Cheung TT, Chan AC, Pang RW, Poon R, Fan ST, Yau T. Oncologist. 2011;16(12):1721-8.
  64. Survival analysis of re-resection versus radiofrequency ablation for intrahepatic recurrence after hepatectomy for hepatocellular carcinoma. Chan AC, Poon RT, Cheung TT, Chok KS, Chan SC, Fan ST, Lo CM. World J Surg. 2012 Jan;36(1):151-6.
  65. Survival advantage of primary liver transplantation for hepatocellular carcinoma within the up-to-7 criteria with microvascular invasion. Chan SC, Fan ST, Chok KS, Cheung TT, Chan AC, Fung JY, Poon RT, Lo CM. Hepatol Int. 2011 Oct 21.
  66. High-intensity focused ultrasound as a treatment for colorectal liver metastasis in difficult position. Cheung TT, Poon RT, Yau T, Tsang DS, Lo CM, Fan ST.Int J Colorectal Dis. 2011 Aug 13.
  67. Entecavir monotherapy is effective in suppressing hepatitis B virus after liver transplantation. Fung J, Cheung C, Chan SC, Yuen MF, Chok KS, Sharr W, Dai WC, Chan AC, Cheung TT, Tsang S, Lam B, Lai CL, Lo CM. Gastroenterology. 2011 Oct;141(4):1212-9.
  68. Can positron emission tomography with the dual tracers [11 C]acetate and [18 F]fludeoxyglucose predict microvascular invasion in hepatocellular carcinoma? Cheung TT, Chan SC, Ho CL, Chok KS, Chan AC, Sharr WW, Ng KK, Poon RT, Lo CM, Fan ST.Liver Transpl. 2011 Oct;17(10):1218-25.
  69. Late recurrence of hepatocellular carcinoma after liver transplantation. Chok KS, Chan SC, Cheung TT, Chan AC, Fan ST, Lo CM. World J Surg. 2011 Sep;35(9):2058-62.
  70. High-intensity focused ultrasound for hepatocellular carcinoma: a single-center experience. Ng KK, Poon RT, Chan SC, Chok KS, Cheung TT, Tung H, Chu F, Tso WK, Yu WC, Lo CM, Fan ST. Ann Surg. 2011 May;253(5):981-7.
  71. Bile duct anastomotic stricture after adult-to-adult right lobe living donor liver transplantation. Chok KS, Chan SC, Cheung TT, Sharr WW, Chan AC, Lo CM, Fan ST. Liver Transpl. 2011 Jan;17(1):47-52.
  72. A rare cause for peritonitis: pancreatic heterotopia. She WH, Cheung TT [Corresponding Author] Int J Colorectal Dis. 2010 Jul 31.
  73. Results of percutaneous transhepatic cholecystostomy for high surgical risk patients with acute cholecystitis.Chok KS, Chu FS, Cheung TT, Lam VW, Yuen WK, Ng KK, Chan SC, Poon RT, Yeung C, Lo CM, Fan ST.ANZ J Surg. 2010 Apr;80(4):280-3.
  74. Combined resection and radiofrequency ablation for multifocal hepatocellular carcinoma: prognosis and outcomes.Cheung TT, Ng KK, Chok KS, Chan SC, Poon RT, Lo CM, Fan ST. World J Gastroenterol. 2010 Jun 28;16(24):3056-62.
  75. A case of laparoscopic hepatectomy for recurrent hepatocellular carcinoma. Cheung TT, Ng KK, Poon RT, Chan SC, Lo CM, Fan ST. World J Gastroenterol. 2010 Jan 28;16(4):526-30.
  76. Radiofrequency ablation for controlling iatrogenic splenic injury. Dai WC, Ng KK, Chok KS, Cheung TT, Poon RT, Fan ST. Int J Colorectal Dis. 2010 May;25(5):667-8.
  77. Is sentinel lymph node biopsy after neoadjuvant chemotherapy feasible in Chinese patients with invasive breast cancers? Cheung TT, Suen DT, Kwong A. ANZ J Surg. 2009 Oct;79(10):719-23.
  78. Liver transplantation for hepatocellular carcinoma: the Hong Kong experience. Ng KK, Lo CM, Chan SC, Chok KS, Cheung TT, Fan ST. J Hepatobiliary Pancreat Sci. 2010 Sep;17(5):548-54.
  79. The outcomes of elderly patients with hepatocellular carcinoma treated with tranarterial chemoembolization. Yau T, Yao TJ, Chan P, Epstein RJ, Ng KK, Chok SH, Cheung TT, Fan ST, Poon RT. Cancer. 2009 Dec 1;115(23):5507-15.
  80. An update on long-term outcome of curative hepatic resection for hepatocholangiocarcinoma. Chok KS, Ng KK, Cheung TT, Yuen WK, Poon RT, Lo CM, Fan ST. World J Surg. 2009 Sep;33(9):1916-21.
  81. Tolerance of radiofrequency ablation by patients of hepatocellular carcinoma. Cheung TT, Ng KK, Poon RT, Fan ST. J Hepatobiliary Pancreat Surg. 2009;16(5):655-60.
  82. Phase 2 open-label study of single-agent sorafenib in treating advanced hepatocellular carcinoma in a hepatitis B-endemic Asian population: presence of lung metastasis predicts poor response. Yau T, Chan P, Ng KK, Chok SH, Cheung TT, Fan ST, Poon RT. Cancer. 2009 Jan 15;115(2):428-36.
  83. Safety and efficacy of radiofrequency ablation for periductal hepatocellular carcinoma with intraductal cooling of the central bile duct.Lam VW, Ng KK, Chok KS, Cheung TT, Wat J, Fan ST, Poon RT.J Am Coll Surg. 2008 Aug;207(2):e1-5.
  84. Risk factors and prognostic factors of local recurrence after radiofrequency ablation of hepatocellular carcinoma.Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT.J Am Coll Surg. 008 Jul;207(1):20-9.
  85. Efficacy and tolerability of low-dose thalidomide as first-line systemic treatment of patients with advanced hepatocellular carcinoma.Yau T, Chan P, Wong H, Ng KK, Chok SH, Cheung TT, Lam V, Epstein RJ, Fan ST, Poon RT.Oncology. 2007;72 Suppl 1:67-71.
  86. Incomplete ablation after radiofrequency ablation of hepatocellular carcinoma: analysis of risk factors and prognostic factors.Lam VW, Ng KK, Chok KS, Cheung TT, Yuen J, Tung H, Tso WK, Fan ST, Poon RT.Ann Surg Oncol. 2008 Mar;15(3):782-90.
  87. Laparoscopic inguinal hernia repair in children.Cheung TT, Chan KL ANNALS OF THE COLLEGE OF SURGEONS OF HONG KONG.Volume 7, Issue 3, August 2003, Pages: 94–96
  88. Varicocele: Laparoscopic clipping and color Doppler follow-up.Sun N, Cheung TT, Khong PL, Chan KL, Tam PK.J Pediatr Surg. 2001 Nov;36(11):1704-7
  89. The experience of sentinel lymph node biopsy in breast cancer patients with prior neo-adjuvant chemotherapy.Suen DTK, Cheung TT, Kwong A.Surgical Practice 2006.

 


Cheung Tan To

Associate Professor

 

 

: 852 22553025
  • DEPARTMENT Department of Hepatobiliary
    and Pancreatic Surgery
    University of Hong Kong
  • COUNTRYHong Kong